From the Department of Neurology (P.T.A.) and the Section of
Neuroradiology, Mallinckrodt Institute of Radiology (T.K.P., C.J.M., D.T.C.),
Washington University School of Medicine, St Louis, Mo, and Mercy Healthcare
Sacramento (P.T.A.), Sacramento, Calif.
Correspondence to Paul T. Akins, MD, PhD, Mercy Healthcare Sacramento, 2825 J St, Suite 435, Sacramento, CA 95816. E-mail akins{at}cwnet.com
MethodsWe retrospectively reviewed records over a 7-year
period to identify patients with intracranial atherosclerotic
stenoses and serial angiograms. Quantitative measurements of
stenoses were made in a blinded manner, and clinical outcomes
were reviewed.
ResultsWe identified 21 patients with 45 intracranial
stenoses who underwent repeat angiography at an average
interval of 26.7 months. The average stenosis for all
intracranial lesions was 43.9% initially and 51.8% on follow-up
(P=.032). The average stenosis in the
intracranial internal carotid artery (ICA) was stable (51.2% versus
52.6%). The average stenosis in the anterior cerebral artery
(ACA), middle cerebral artery (MCA), and posterior cerebral artery
(PCA) progressed from 32.4% to 49.7% (P=.037). Based
on a minimum 10% change, 20% of intracranial ICA lesions progressed
compared with 61% of ACA, MCA, and PCA lesions. Regression occurred in
14% of the intracranial ICA group and 28% of the ACA-MCA-PCA group.
Cerebrovascular events were infrequent during this period, with 4
transient ischemic attacks and 1 intracerebral
hemorrhage.
ConclusionsIntracranial atherosclerotic stenoses are dynamic
lesions demonstrating both progression and regression.
The increased risk inpatients with intracranial
atherosclerosis for stroke, heart disease, and death
has been consistently observed.2 9 10 11 12 13 14
For example, in patients with stenosis of the intracranial ICA,
mortality as high as 50% over an average 3.9-year period has been
reported.9 A retrospective, multicenter
study14 has reported clinical outcomes of
symptomatic patients with angiographically defined
stenoses of 50% to 99% in an intracranial artery and
ischemic events involving the territory of the stenotic
vessel. Over a median follow-up of 19.3 months in patients treated with
aspirin, 24% had a stroke, and 17% had myocardial infarction or
sudden death. In this study, patients treated with warfarin had fewer
ischemic strokes and myocardial infarctions but more
intracerebral hemorrhages. In the medically
managed arm of a trial of EC/IC bypass surgery,11
36% of patients with high-grade distal ICA stenoses and 24%
of patients with MCA stenoses treated with aspirin had strokes
(overall average follow-up for study was 55.8 months).
The management of these high-risk patients is controversial. Based on
retrospective data, warfarin may be superior to antiplatelet
therapy, but these two treatments have not been compared
prospectively.14 EC/IC bypass surgery for
patients with high-grade ICA or MCA stenosis did not reduce the
risk of stroke over aspirin treatment alone.11
Cerebral percutaneous transluminal angioplasty has been
performed in patients refractory to medical
treatment.15 16 17 18 19 20 Compared with extracranial
vessels, angioplasty of intracranial vessels has a higher complication
rate, with strokes occurring in 12% to 33% of
cases.15 18 20 Complications have been attributed
to vessel dissection, thromboembolism, occlusion of small perforating
vessels, and selection bias for high-risk patients in whom
anticoagulation treatment has failed. Clinical and angiographic
follow-up is limited but encouraging.
The long-term angiographic behavior of intracranial atherosclerotic
stenoses has not received much attention. Bauer et
al21 reported the results of serial cerebral
angiography in 49 patients with strokes or TIAs with an average
follow-up interval of 25 months. They reported progression of
atherosclerotic stenoses by location, including extracranial
and intracranial sites. Overall, 35.3% of intracranial sites
progressed. Craig et al2 reported that
intracranial ICA stenoses progressed in 5 of 5 patients on
follow-up angiography. In the setting of EC/IC bypass, 9 of 18
stenoses showed significant angiographic changes on follow-up
studies: 4 sites occluded and 5 sites improved.22
For example, an 80% stenosis of the carotid siphon completely
resolved, but the bypass occluded. We conducted a retrospective study
of patients with intracranial atherosclerotic stenoses who had
undergone repeat angiography at our institution to learn more about the
natural history of these lesions.
Cerebral angiograms from 23 patients were initially reviewed in an
unblinded manner. We routinely assessed the following vessels for
atherosclerotic stenoses of 50% or greater: the intracranial
portion of the ICA; the ACA, MCA, and PCA; the distal vertebral and
basilar arteries; and the origins of the posterior inferior
cerebellar and superior cerebellar arteries. When available, the
carotid bifurcations were also reviewed, and the side without interval
endarterectomy was identified. The indication for
repeat angiography was recorded. Two patients were excluded: one
for stenoses of less than 50%, and one for large
subarachnoid hemorrhage. Clinical information regarding
the indication for repeat angiography, atherosclerotic disease risk
factors, secondary stroke prevention measures, functional status, and
strokes or transient ischemic attacks were obtained by a chart
review and phone contact with the patient or immediate relative.
A total of 45 stenoses suitable for serial measurement were
identified in 21 patients. Initial and follow-up films were
simultaneously viewed. These lesions were well-visualized
in the same projection and at a similar arterial phase.
Intracranial stenoses that constituted the distal half of
tandem lesions were excluded. The maximum stenosis and a nearby
adjacent "normal" segment were outlined with a sharp, soft lead
pencil on the initial and follow-up studies. The "normal" segment
was either proximal or distal to the lesion. For a given
stenosis, the same control segment was used. The angiograms
were randomly coded A or B, and the identifying data were obscured with
a black film mask. On a different day, measurements of stenoses
and the "normal" segment were performed by a single observer using
a 10x loupe to the nearest 0.1 mm. The percentage of
stenosis was calculated by the following formula:
{1-(stenosis/normal segment)}x100.
The measurement reproducibility was evaluated with use of test-retest
analysis by repeating the measurements at 30 randomly selected
stenoses from this patient series. Both the stenosis
and denominator were remeasured, and the percent stenosis was
recalculated. The level of agreement was very high. The repeat values
were unbiased, as the 95% confidence interval for the mean difference
between original and repeat measures included zero. The standard
deviations of the differences between the measures were 0.18 mm
for stenosis, 0.39 mm for denominator, and 4.25% for
percent stenosis. Simple linear regression was used to fit
lines describing the relation between the original and repeat measures.
The relation appears to be one-to-one, as a slope of one was included
in all the 95% confidence intervals for slope and zero was included in
all the 95% confidence intervals for intercept. In all cases,
r2 was at least 0.96. Consequently, a 10%
change in percent stenosis was chosen as a threshold for
determining whether an individual lesion had progressed or regressed;
this difference is greater than 2 SDs for percent stenosis
remeasurement, which eliminates the possibility that the difference
could arise from measurement error.
Quantitative measurements of the carotid bifurcation and intracranial
stenoses were performed in a blinded manner following an
initial, unblinded screening of films. Examples of stenoses are
provided (Figs 1 through 7
The average stenosis for all intracranial sites worsened from
43.9% (range, 0% to 100%; SD, 22.3%) to 51.8% (range, 0% to
100%; SD, 15.9%) (Fig 8
The intracranial lesions were divided into three groups: (1)
intracranial ICA segment (petrous to supraclinoid portion); (2) ACA,
MCA, and PCA; and (3) distal vertebral and basilar arteries and their
branches. The mean stenosis for lesions of the ACA, MCA, and
PCA progressed (P=.037 by one-sided t test),
whereas the mean stenosis for the intracranial ICA was stable
(Fig 8
The frequency of lesion progression for intracranial stenoses
is consistent with previous angiographic
studies.2 21 22 Progression of stenoses
has also been reported with use of serial transcranial
Doppler measurements.23 We offer several
possible explanations for the relative stability of the intracranial
ICA lesions compared with those in other intracranial sites. First, for
similar absolute changes in luminal narrowing, the change in percent
stenosis will be greater for small vessels compared with large
vessels. Consider a stenosis that progresses from 3 mm to
2 mm. If the normal segment is 5 mm, the percent
stenosis will progress from 40% to 60% (20% change). If the
normal segment is 10 mm, the percent stenosis will
progress from 70% to 80% (10% change). Second, the smaller vessels
may be more prone to local thrombus formation compared with the
intracranial ICA. Third, certain intracranial vessels have a
predilection for
atherosclerosis.1 3 4 14 The
distribution of lesions in our series is fairly
representative of this pattern. It would be reasonable
to expect that once focal lesions form in these vulnerable locations,
they would advance more quickly compared with other sites. Fourth, the
retrospective nature of this study and the requirement for repeat
angiography introduce significant selection biases. For example, most
clinicians would not perform repeat angiography in a patient with a
known intracranial ICA stenosis who suffers a large ipsilateral
stroke outside of the setting of intra-arterial
thrombolysis.
Only one potential risk factor for lesion progression, the absence of
carotid bifurcation disease, was noted on bivariate analysis.
The significance of this finding is diminished by the small size of the
study and the numerous risk factors assessed. Other
investigators have noted the low frequency of carotid bifurcation
disease in ethnic groups prone to develop intracra nial
disease.4 In an angiography-based study, the
duration of tobacco use was the most significant predictor of
intracranial ICA atherosclerosis, followed by
hypertension and diabetes.8
While serial angiography has rarely been used to investigate
intracranial atherosclerosis, coronary artery
disease has been extensively researched using serial angiography. This
approach has been very instructive. Angiographic progression of
coronary atherosclerosis is associated with an
increased risk of a clinical coronary
event.24 25 26 27 For example, in a trial of
partial ileal bypass for hyperlipidemia with serial
coronary angiography at 0, 3, 5, 7, and 10 years, medically
managed patients with qualitative progression in coronary
artery disease had a twofold increase in mortality compared with
patients with stable or regressing disease.25
Strategies to treat hyperlipidemia (eg,
lovastatin or colestipol and niacin) have
consistently demonstrated that coronary lesions could
stabilize and regress.26 Many trials used
qualitative scales for change and calculated percent stenosis
using an adjacent "normal" segment. More recent studies have
developed computer-assisted quantitative coronary angiography.
When serial quantitative measurements are made, the average diameter of
coronary vessels without focal narrowing has mild progression
in about 25% of patients studied. Compensatory vessel dilation at the
initial site of
atherosclerosis26 28 29 as well
as distal to the stenosis30 has been well
documented in coronary vessels. It is likely that similar
responses occur in cerebral vessels (Fig 3
This study has provided information about the spectrum of changes that
can be observed in stenoses associated with intracranial
atherosclerosis. Lesion progression occurs frequently
in patients with intracranial atherosclerosis,
particularly in medium-sized vessels. In this study, intracranial ICA
lesions were more stable than other sites. Lesion regression clearly
occurs in some patients. The pathological process that leads to this
angiographic improvement may be regression of
atherosclerosis or resolution of local thrombus or
both. These results may be useful when designing studies to investigate
potential therapies for this high-risk population. Such studies will
need to include a control group, because some patients with
intracranial disease can have a benign clinical course and spontaneous
regression of intracranial stenoses.
Received September 2, 1997;
revision received November 6, 1997;
accepted November 24, 1997.
2.
Craig DR, Mageuro K, Watridge C, Robertson JT, Barnett
HJM, Fox AJ. Intracranial internal carotid artery
stenosis. Stroke. 1982;13:825828.
3.
Moosy J. Cerebral infarcts and the lesions of
intracranial and extracranial atherosclerosis.
Arch Neurol. 1966;14:124128.
4.
Caplan LR, Gorelick PB, Hier DB. Race, sex, and
occlusive cerebrovascular disease: a review. Stroke. 1986;17:648655.
5.
Moossy J. Pathology of cerebral
atherosclerosis: influence of age, race, and gender.
Stroke. 1993;24(suppl I):I-22-I-23.
6.
Leung SY, Ng THK, Yuen ST, Lauder IJ, Ho FCS. Pattern
of cerebral atherosclerosis in Hong Kong Chinese:
severity in intracranial and extracranial vessels. Stroke. 1993;24:779786.
7.
Sacco RL, Kargman DE, Gu Q, Zamanillo MC.
Race-ethnicity and determinants of intracranial atherosclerotic
cerebral infarction: The Northern Manhattan Stroke Study.
Stroke. 1995;26:1420.
8.
Ingall TJ, Homer D, Baker HL Jr, Kottke BA, O'Fallon
WM, Whisnant JP. Predictors of intracranial carotid artery
atherosclerosis: duration of cigarette smoking and
hypertension are more powerful than serum lipid levels. Arch
Neurol. 1991;48:687691.
9.
Marzewski DJ, Furlan AJ, St Louis P, Little JR, Modic
MT, Williams G. Intracranial internal carotid artery stenosis:
long-term prognosis. Stroke. 1982;13:821824.
10.
Bogousslavsky J, Regli F. Prognosis of
symptomatic intracranial obstruction of internal carotid
artery. Eur Neurol. 1983;22:351358.[Medline]
[Order article via Infotrieve]
11.
The EC/IC Bypass Study Group. Failure of
extracranial-intracranial arterial bypass to reduce the
risk of ischemic stroke: results of an international randomized
trial. N Engl J Med. 1985;313:11911200.[Abstract]
12.
Moufarrij NA, Little JR, Furlan AJ, Leatherman JR,
Williams GW. Basilar and distal vertebral artery stenosis:
long-term follow-up. Stroke. 1986;17:938942.
13.
Raju S, Fredericks RK. Carotid siphon stenosis.
J Cardiovasc Surg. 1987;28:671677.[Medline]
[Order article via Infotrieve]
14.
Chimowitz MI, Kokkinos J, Strong J, Brown MD, Levine
SR, Silliman S, Pessin MS, Weichel E, Sila CA, Furlan AJ, Kargman DE,
Sacco RL, Wityk RJ, Ford G, Fayad PB for the Warfarin-Aspirin
Symptomatic Intracranial Disease Study Group. The
Warfarin-Aspirin Symptomatic Intracranial Disease Study.
Neurology. 1995;45:14881493.
15.
Higashida RT, Tsai FY, Halbach VV, Dowd CF, Hieshima
GB. Cerebral percutaneous transluminal angioplasty.
J Heart Dis Stroke. 1993;2:497502.
16.
Ferguson RDG, Ferguson JG, Lee LI. Endovascular
revascularization therapy in cerebral
athero-occlusive disease: angioplasty and stents, systemic and local
thrombolysis. Neurosurg Clin N Am. 1994;5:511527.[Medline]
[Order article via Infotrieve]
17.
Higashida RT, Halbach VV, Tsai FY, Dowd CF. Hieshima
GB. Interventional neurovascular techniques for cerebral
revascularization in the treatment of stroke.
AJR. Am J Roentgenol.. 1994;163:793800.
18.
Clark WM, Barnwell SL, Nesbit G, O'Neill OR, Wynn ML,
Coull BM. Safety and efficacy of percutaneous
transluminal angioplasty for intracranial atherosclerotic
stenosis. Stroke. 1995;26:12001204.
19.
Houdart E, Ricolfi F, Brugieres P, Antoine JC, Gaston
A. Percutaneous transluminal angioplasty of
atherosclerotic basilar artery stenosis.
Neuroradiology. 1996;38:383385.
20.
Terada T, Higashida RT, Halbach VV, Dowd CF, Nakai E,
Yokote H, Itakura T, Hieshima GB. Transluminal angioplasty for
arteriosclerotic disease of the distal vertebral
and basilar arteries. J Neurol Neurosurg Psychiatry. 1996;60:377381.
21.
Bauer RB, Boulos RS, Meyer JS. Natural history and
surgical treatment of occlusive cerebrovascular disease evaluated by
serial arteriography. AJR Am J Roentgenol Radium
Ther Nucl Med. 1968;104:117.[Medline]
[Order article via Infotrieve]
22.
Awad I, Furlan AJ, Little JR. Changes in intracranial
stenotic lesions after extracranial-intracranial bypass
surgery. J Neurosurg. 1984;60:771776.[Medline]
[Order article via Infotrieve]
23.
Schwarze JJ, Babikian V, DeWitt LD, Sloan MA, Wechsler
LR, Gomez CR, Pochay V, Baker E Longitudinal monitoring of intracranial
arterial stenoses with transcranial
Doppler ultrasonography. J Neuroimaging. 1994;4:182187.[Medline]
[Order article via Infotrieve]
24.
Moise A, Bourassa MG, Théroux P, Taeymans Y,
Pasternac A, Campeau L, Bois MA, Dyrda I, David PR. Prognostic
significance of progression of coronary artery disease.
Am J Cardiol. 1985;55:941946.[Medline]
[Order article via Infotrieve]
25.
Buchwald H, Matts JP, Fitch LL, Campos CT, Sanmarco ME,
Amplatz K, Castaneda-Zuniga WR, Hunter DW, Pearce MB, Bissett JK,
Edmiston A, Sawin HS, Weber FJ, Varco RL, Campbell GS, Yellin AE, Smink
RD, Long JM, Hansen BJ, Chalmers TC, Meier P, Stamler J, for the POSCH
Group. Changes in sequential coronary arteriograms and
subsequent coronary events. JAMA. 1992;268:14291433.
26.
Blankenhorn DH, Hodis HN. George Lyman Duff Memorial
Lecture. Arterial imaging and
atherosclerosis reversal. Arterioscler
Thromb. 1994;14:177192.
27.
Azen SP, Mack WJ, Cashin-Hemphill L, LaBree L, Shircore
AM, Selzer RH, Blankenhorn DH, Hodis HN. Progression of
coronary artery disease predicts clinical coronary
events: long-term follow-up from the Cholesterol Lowering
Atherosclerosis Study. Circulation. 1996;93:3441.
28.
Glasgov S, Weisenberg E, Zarins CK, Stankunavicius R,
Kolettis GJ. Compensatory enlargement of human atherosclerotic
coronary arteries. N Engl J Med. 1987;316:13711375.[Abstract]
29.
Fishbein MC, Siegel RJ. How big are coronary
atherosclerotic plaques that rupture? Circulation. 1996;94:26622666.
30.
Shircore AM, Mack WJ, Selzer RH, Lee PL, Azen SP,
Alaupovic P, Hodis HN. Compensatory vascular changes of remote
coronary segments in response to lesion progression as observed
by sequential angiography from a controlled clinical trial.
Circulation. 1995;92:24112418.
© 1998 American Heart Association, Inc.
Original Contributions
Natural History of Stenosis From Intracranial Atherosclerosis by Serial Angiography
![]()
Abstract
Top
Abstract
Introduction
Subjects and Methods
Results
Discussion
References
Background and PurposeKnowledge of
the natural history of stenoses due to intracranial
atherosclerosis may be useful for evaluating possible
treatments such as angioplasty.
Key Words: angioplasty atherosclerosis cerebral angiography cerebral ischemia cerebral ischemia, transient
![]()
Introduction
Top
Abstract
Introduction
Subjects and Methods
Results
Discussion
References
Patients with
intracranial atherosclerotic disease are at increased risk of stroke
and heart disease. Atherosclerosis of the intracranial
vessels frequently occurs in the setting of widespread vascular
disease.1 2 Atherosclerosis may
also develop selectively in intracranial vessels, particularly in
blacks and Asians.3 4 5 6 7 In addition to race, other
risk factors for intracranial atherosclerosis include
age, hypertension, smoking, diabetes, and lipid
disorders.3 4 5 6 7 8
![]()
Subjects and Methods
Top
Abstract
Introduction
Subjects and Methods
Results
Discussion
References
Approval from the Human Studies Committee was obtained for this
retrospective study. We conducted a computer search of the Mallinckrodt
Institute of Radiology files and identified 855 patients who had
undergone two or more cerebral angiograms during the period of July
1990 to June 1997. The most common reason for repeat angiography was
for management of aneurysms, arteriovenous malformations, and
vasospasm. These patients were excluded. We reviewed the dictated
reports of 183 patients whose follow-up angiogram was performed at
least 6 months after the initial study. We identified 28 patients with
moderate or severe atherosclerosis in an intracranial
vessel that was noted in the report. The angiograms from 5 patients
were incomplete or missing.
![]()
Results
Top
Abstract
Introduction
Subjects and Methods
Results
Discussion
References
Clinical features of patients are provided in the Table
. These
diagnoses were based on chart review, using the most current
information available. In many cases, diagnoses of coronary and
peripheral vascular disease were supported by angiography.
Indications for repeat angiography were variable: carotid
bifurcation stenosis or occlusion by carotid ultrasound (62%);
TIA (19%); evaluation for possible arteriovenous malformation (14%);
and to rule out carotid-cavernous fistula (5%). Widespread
atherosclerotic disease involving the carotid bifurcation,
coronary arteries, and peripheral vessels was
present in many patients. The functional status of this group was
high, with 81% of patients receiving a Modified Rankin Score of 0 (no
symptoms) or 1 (able to resume all previous activities despite
symptoms). Many patients had suffered either ischemic (48%) or
hemorrhagic (10%) strokes around the time of the initial cerebral
angiogram. During the period between the first and second angiograms, 4
patients had TIAs and 1 had an intracerebral
hemorrhage. The sample size was too small to investigate
clinical features associated with TIA or intracerebral
hemorrhage. We note that 2 of the 4 patients with TIAs had
progression of the intracranial stenoses. Only one patient died
during the follow-up period (of gastrointestinal hemorrhage).
This represents a 5% mortality for this group over an average
follow-up time of 26.7 months.
View this table:
[in a new window]
Table 1. Characteristics of Patients with Intracranial Stenosis ![]()
![]()
![]()
![]()
![]()
![]()
). The most common location for an intracranial
stenosis of 50% or greater was the intracranial portion of the
ICA (Fig 2
; 49% of lesions), followed by the MCA (Fig 4
; 20%), PCA
(Fig 5
; 11%), distal vertebral and basilar arteries (Figs 6
and 7
;
11%), and ACA (Figs 3
and 7
; 9%).

View larger version (139K):
[in a new window]
Figure 1. The stenosis at the carotid bifurcation
was remeasured in vessels without interval
endarterectomy. Repeat angiography with a slightly
more lateral view performed 3 years (y) 4 months (m) later demonstrates
progression of internal carotid artery stenosis (arrow). The
vertebrobasilar vessels of this patient are shown in Fig 6
.

View larger version (75K):
[in a new window]
Figure 2. The IC-ICA was the most frequent site for
stenoses. Despite the ulcerated appearance, this lesion did not
change significantly.

View larger version (60K):
[in a new window]
Figure 3. A long stenosis of the pericallosal branch
of the anterior cerebral artery is shown (horizontal arrow). On repeat
study, the middle cerebral artery stenosis has progressed, and
the poststenotic region (vertical arrow) appears to have
compensatory dilation.

View larger version (86K):
[in a new window]
Figure 4. A proximal middle cerebral artery stenosis
(white arrow) remains stable on repeat study. Distally, a
stenosis develops in a normal appearing segment (black arrow).
The distal narrowing most likely represents thromboembolus
originating from the proximal stenosis rather than progression
of atherosclerosis.

View larger version (65K):
[in a new window]
Figure 5. Follow-up angiography demonstrates
stenosis of the posterior cerebral artery (arrow).

View larger version (101K):
[in a new window]
Figure 6. Diffuse atherosclerosis of the
distal vertebral artery and the vertebrobasilar junction shows slight
progression over an 11-year 8-month period. This lesion illustrates the
difficulty in defining a "normal" reference segment. In this
patient, atherosclerosis at the carotid bifurcation
advanced over a shorter interval (Fig 1
).

View larger version (123K):
[in a new window]
Figure 7. Lesion regression was encountered in a minority of
lesions. A, Spontaneous recanalization of the
anterior cerebral artery is demonstrated. This vessel has several areas
of stenosis. This same patient had a 70% distal vertebral
artery stenosis on initial study that was occluded on the
repeat study. The patient did not report any symptoms of stroke or TIA.
B, A distal vertebral stenosis was noted on the initial study
in this patient with left subclavian steal. The repeat study shows
marked regression of the stenosis and mild vessel
irregularity.
;
P=.032 by one-sided t test). Bivariate
analysis with ANOVA and t test was performed for
potential risk factors for disease progression. The following factors
were evaluated: age, sex, race, interval between angiograms, diabetes,
hypertension, tobacco use,
hypercholesterolemia, chronic ethanol use, and
carotid bifurcation disease (>50% stenosis). Patients without
carotid bifurcation disease were more likely to progress (n=9; average
change, +24.7%) than those with extracranial disease (n=36; average
change, +3.8%; P=.045 by paired t test). The
average stenosis of the carotid bifurcation did not change
significantly; however, we did not measure the stenosis if the
patient underwent interval endarterectomy.

View larger version (15K):
[in a new window]
Figure 8. The average stenosis and standard error
for vessels on initial (white bars) and follow-up (black) angiograms is
shown according to site. The mean stenosis on follow-up
angiogram measured for the overall group (P=.032) and
for the ACA/MCA/PCA group (P=.037) has significantly
progressed compared with the initial angiogram.
). The number of lesions studied in the intracranial
vertebrobasilar system was small. Lesions were categorized into
stabilization, progression, or regression, if a change of 10% or
greater was observed (Fig 9
). Based on
test-retest analysis, a 10% difference was reliably detected
using our measurement technique. Overall, 40% of intracranial
stenoses were stable, 20% regressed, and 40% progressed.
Lesions in the intracranial ICA were less likely to progress compared
with those in other sites. Only two occlusions were studied. Both
occurred in the same patient and were asymptomatic. The
anterior cerebral artery spontaneously reperfused, demonstrating
several diseased segments (Fig 7
), and the right vertebral artery, with
an initial 70% distal stenosis, occluded. In three sites,
striking regression occurred with a residual stenosis of less
than 20% (Fig 7
), suggesting that a significant component of the
stenosis was thrombus.

View larger version (27K):
[in a new window]
Figure 9. Stenoses present in the ACAs, MCAs,
and PCAs were dynamic lesions likely to either regress (white sections)
or progress (black) rather than remain stable (gray). In contrast,
stenoses in the IC portion of the ICA were more stable. Lesions
in the IC portion of the vertebrobasilar system were also dynamic, but
only a small number (n=5) were studied. Less than 10% change in
stenosis was considered stable.
![]()
Discussion
Top
Abstract
Introduction
Subjects and Methods
Results
Discussion
References
In this series of patients with intracranial atherosclerotic
stenoses, repeat angiography demonstrated the dynamic nature of
these lesions. Angiography is an excellent method for monitoring
atherosclerosis, but some limitations should be noted.
This method defines the vessel lumen only. The disease process leading
to luminal narrowing is inferred. If the patient has widespread
atherosclerosis, the stenosis is usually
ascribed to this. Based on pathological
specimens,1 3 4 the narrowing is generally caused
by local atherosclerosis, but associated thrombus may
also contribute. Emboli also cause luminal narrowing. In this
situation, the follow-up study may show complete resolution of the
stenosis due to spontaneous clot lysis. This pattern was
encountered in 3 of the 45 sites studied.
Physiological variables such as cerebral
autoregulation in response to PCO2 and
vessel pulsation from the cardiac cycle can affect vessel diameter.
Pathophysiological processes such as vasculitis,
vasospasm, and certain malignancies, including
glioblastoma multiforme and intravascular lymphoma, can also cause
vessel narrowing. None of our patients had clinical features to suggest
these other pathologic conditions.
).
![]()
Selected Abbreviations and Acronyms
ACA
=
anterior cerebral artery
EC/IC
=
extracranial-to-intracranial
ICA
=
internal carotid artery
MCA
=
middle cerebral artery
PCA
=
posterior cerebral artery
TIA
=
transient ischemic attack
![]()
Acknowledgments
Dr Akins received funding through a Department of Public Health
and Human Services training grant, the Seay Fellowship in
Neuropharmacology, and Mercy Healthcare Sacramento. We are grateful for
the expert advice of Dr James Milburn in accurate and reliable
measurement of vessels and appreciate the helpful assistance of Mary
Margaret Fresta in the arduous task of locating remote radiology
films.
![]()
References
Top
Abstract
Introduction
Subjects and Methods
Results
Discussion
References
1.
Fisher CM, Gore I, Okabe N, White PD.
Atherosclerosis of the carotid and vertebral arteries:
extracranial and intracranial. J Neuropathol Exp
Neurol. 1965;24:455476.
This article has been cited by other articles:
![]() |
P. M. Meyers, H. C. Schumacher, R. T. Higashida, S. L. Barnwell, M. A. Creager, R. Gupta, C. G. McDougall, D. K. Pandey, D. Sacks, and L. R. Wechsler Indications for the Performance of Intracranial Endovascular Neurointerventional Procedures: A Scientific Statement From the American Heart Association Council on Cardiovascular Radiology and Intervention, Stroke Council, Council on Cardiovascular Surgery and Anesthesia, Interdisciplinary Council on Peripheral Vascular Disease, and Interdisciplinary Council on Quality of Care and Outcomes Research Circulation, April 28, 2009; 119(16): 2235 - 2249. [Full Text] [PDF] |
||||
![]() |
J. F. Arenillas, J. Alvarez-Sabin, C. A. Molina, P. Chacon, I. Fernandez-Cadenas, M. Ribo, P. Delgado, M. Rubiera, A. Penalba, A. Rovira, et al. Progression of Symptomatic Intracranial Large Artery Atherosclerosis Is Associated With a Proinflammatory State and Impaired Fibrinolysis Stroke, May 1, 2008; 39(5): 1456 - 1463. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Valaikiene, G. Schuierer, B. Ziemus, J. Dietrich, U. Bogdahn, and F. Schlachetzki Transcranial Color-Coded Duplex Sonography for Detection of Distal Internal Carotid Artery Stenosis AJNR Am. J. Neuroradiol., February 1, 2008; 29(2): 347 - 353. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Kern, W. Steinke, M. Daffertshofer, R. Prager, and M. Hennerici Stroke recurrences in patients with symptomatic vs asymptomatic middle cerebral artery disease Neurology, September 27, 2005; 65(6): 859 - 864. [Abstract] [Full Text] [PDF] |
||||
![]() |
O Y Bang, P H Lee, S R Yoon, M A Lee, I S Joo, and K Huh Inflammatory markers, rather than conventional risk factors, are different between carotid and MCA atherosclerosis J. Neurol. Neurosurg. Psychiatry, August 1, 2005; 76(8): 1128 - 1134. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. U. Kwon, Y.-J. Cho, J.-S. Koo, H.-J. Bae, Y.-S. Lee, K.-S. Hong, J. H. Lee, and J. S. Kim Cilostazol Prevents the Progression of the Symptomatic Intracranial Arterial Stenosis: The Multicenter Double-Blind Placebo-Controlled Trial of Cilostazol in Symptomatic Intracranial Arterial Stenosis Stroke, April 1, 2005; 36(4): 782 - 786. [Abstract] [Full Text] [PDF] |
||||
![]() |
J K Kim, J Y Ahn, B H Lee, Y S Chung, S S Chung, O J Kim, W C Kim, and J Y Joo Elective stenting for symptomatic middle cerebral artery stenosis presenting as transient ischaemic deficits or stroke attacks: short term arteriographical and clinical outcome J. Neurol. Neurosurg. Psychiatry, June 1, 2004; 75(6): 847 - 851. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Y. Bang, S. Y. Joo, P. H. Lee, U. S. Joo, J. H. Lee, I. S. Joo, and K. Huh The Course of Patients With Lacunar Infarcts and a Parent Arterial Lesion: Similarities to Large Artery vs Small Artery Disease Arch Neurol, April 1, 2004; 61(4): 514 - 519. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. du Mesnil de Rochemont, B. Turowski, M. Buchkremer, M. Sitzer, F. E. Zanella, and J. Berkefeld Recurrent Symptomatic High-Grade Intracranial Stenoses: Safety and Efficacy of Undersized Stents-- Initial Experience Radiology, April 1, 2004; 231(1): 45 - 49. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Iancu-Gontard, C. Oppenheim, E. Touze, E. Meary, M. Zuber, J.-L. Mas, D. Fredy, and J.-F. Meder Evaluation of Hyperintense Vessels on FLAIR MRI for the Diagnosis of Multiple Intracerebral Arterial Stenoses Stroke, August 1, 2003; 34(8): 1886 - 1891. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ogasawara, A. Ogawa, and T. Yoshimoto Cerebrovascular Reactivity to Acetazolamide and Outcome in Patients With Symptomatic Internal Carotid or Middle Cerebral Artery Occlusion: A Xenon-133 Single-Photon Emission Computed Tomography Study Stroke, July 1, 2002; 33(7): 1857 - 1862. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Lylyk, J. E. Cohen, R. Ceratto, A. Ferrario, and C. Miranda Angioplasty and Stent Placement in Intracranial Atherosclerotic Stenoses and Dissections AJNR Am. J. Neuroradiol., March 1, 2002; 23(3): 430 - 436. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. S. Wong, H. Li, W. W.M. Lam, Y. L. Chan, and R. Kay Progression of Middle Cerebral Artery Occlusive Disease and Its Relationship With Further Vascular Events After Stroke Stroke, February 1, 2002; 33(2): 532 - 536. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Arenillas, C. A. Molina, J. Montaner, S. Abilleira, M. A. Gonzalez-Sanchez;, and J. Alvarez-Sabin Progression and Clinical Recurrence of Symptomatic Middle Cerebral Artery Stenosis: A Long-Term Follow-Up Transcranial Doppler Ultrasound Study Stroke, December 1, 2001; 32(12): 2898 - 2904. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R. Gomez and S. C. Orr Angioplasty and Stenting for Primary Treatment of Intracranial Arterial Stenoses Arch Neurol, October 1, 2001; 58(10): 1687 - 1690. [Full Text] [PDF] |
||||
![]() |
T. Segura, J. Serena, M. Castellanos, J. Teruel, C. Vilar, and A. Davalos Embolism in acute middle cerebral artery stenosis Neurology, February 27, 2001; 56(4): 497 - 501. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. C. Nahser, H. Henkes, W. Weber, E. Berg-Dammer, T. A. Yousry, and D. Kuhne Intracranial Vertebrobasilar Stenosis:Angioplasty and Follow-up AJNR Am. J. Neuroradiol., July 1, 2000; 21(7): 1293 - 1301. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Kappelle, M. Eliasziw, A. J. Fox, B. L. Sharpe, and H. J. M. Barnett Importance of Intracranial Atherosclerotic Disease in Patients With Symptomatic Stenosis of the Internal Carotid Artery Stroke, February 1, 1999; 30(2): 282 - 286. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1998 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |